Sachsenheimer, Daniela
4 papers on CoChat
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study
Pfützner, A., Sachsenheimer, D., Grenningloh, M., Heschel, M., Walther-Johannesen, L., Gharabli, R., & Klonoff, D. (2015) · Journal of Diabetes Science and Technology
Diabetes Management and ResearchIntravenous Infusion Technology and Safety
Cited by 53
- Verified
Impact of xylose on glucose-dehydrogenase-based blood glucose meters for patient self-testing
Pfützner, A., Demircik, F., Sachsenheimer, D., Spatz, J., Pfützner, A. H., & Ramljak, S. (2017) · Journal of Diabetes Science and Technology
Clinical Laboratory Practices and Quality ControlDiabetes Management and Research
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free